ALTEOGEN

196170 · KRX · KRW

₩259,500.00−2.08%−₩5,500.00

Close · October 2, 2026

Latest news

Alteogen wins Japan sales approval for ALT-B4 subcutaneous ‘Keytruda’ formulation (opens in a new tab)
더바이오 · Oct 1, 2026
Alteogen Signs Up to $3.22 Billion Licensing Deal With Novartis for Subcutaneous Drug Technology (opens in a new tab)
알파경제 · Sep 3, 2026